Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma
Public ClinicalTrials.gov record NCT06223516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Phase 1b, Open-label Study of Etentamig (ABBV-383) Administered Subcutaneously in Subjects With Relapsed or Refractory Multiple Myeloma
Study identification
- NCT ID
- NCT06223516
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Subcutaneous (SC) Etentamig Drug
- Intravenous (IV) Etentamig Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2024
- Primary completion
- Jan 31, 2027
- Completion
- Nov 30, 2027
- Last update posted
- Mar 26, 2026
2024 – 2027
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona /ID# 260799 | Phoenix | Arizona | 85054 | — |
| Mayo Clinic Hospital Jacksonville /ID# 262808 | Jacksonville | Florida | 32224 | — |
| Sylvester Comprehensive Cancer Center /ID# 260798 | Miami | Florida | 33136-1002 | — |
| University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 261050 | Ann Arbor | Michigan | 48109 | — |
| Mayo Clinic - Rochester /ID# 262807 | Rochester | Minnesota | 55905-0001 | — |
| Atrium Health Wake Forest Baptist Medical Center /ID# 260807 | Winston-Salem | North Carolina | 27157 | — |
| Wisconsin Medical Center /ID# 261085 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06223516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 26, 2026 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06223516 live on ClinicalTrials.gov.